Genetic variations in ZFP36 and their possible relationship to autoimmune diseases

被引:44
作者
Carrick, Danielle Mercatante
Chulada, Patricia
Donn, Rachelle
Fabris, Martina
McNicholl, Janet
Whitworth, William
Blackshear, Perry J.
机构
[1] NIEHS, Off Clin Res, Res Triangle Pk, NC 27709 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[4] Univ Manchester, Arc EU, Manchester, Lancs, England
[5] Univ Manchester, Ctr Mol Med, Manchester, Lancs, England
[6] Univ Udine, I-33100 Udine, Italy
[7] Ctr Dis Control, Atlanta, GA 30333 USA
关键词
autoimmune disease; genetic association; polymorphisms; tumor necrosis factor alpha; tristetraprolin;
D O I
10.1016/j.jaut.2006.01.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ZFP36 gene codes for TTP, a regulator of TNF alpha. In mice, TTP deficiency results in a systemic autoimmune inflammatory syndrome with severe arthritis. We hypothesized that genetic variations in ZFP36 are associated with autoimmune disease in humans. The primary objective of this study was to identify human ZFP36 genetic variants in autoimmune disease cases and controls, determine their frequencies in a general clinic population, and construct haplotypes. We resequenced ZFP36 in 316 individuals with autoimmune diseases and identified 28 polymorphisms and determined the frequency of all the known ZFP36 polymorphisms in 484 participants of the Environmental Polymorphism Registry, a regional registry being conducted by the NIEHS. Based on the sequence-verified ZFP36 genotypes, 34 haplotypes were constructed. As a secondary objective, we examined autoimmune disease cases and controls for potential ZFP36 genetic associations. One novel polymorphism, ZFP36*8, a C to T transition in the protein coding domain, was significantly associated with rheumatoid arthritis (RA) in African-Americans (RR = 1.23, 95% CI: 1.11-1.36). The data presented here suggest a tentative association between ZFP36 and RA. This finding, as well as the ZFP36 polymorphisms and haplotypes identified here, should form the basis for future association studies in autoimmune diseases. Published by Elsevier Ltd.
引用
收藏
页码:182 / 196
页数:15
相关论文
共 44 条
[1]   Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders [J].
Abuzakouk, M ;
Feighery, C ;
Jackson, J .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2002, 59 (03) :173-179
[2]  
[Anonymous], 2000, ARLEQUIN SOFTWARE PO
[3]   Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover [J].
Blackshear, PJ .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :945-952
[4]   Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins [J].
Blackshear, PJ ;
Phillips, RS ;
Vazquez-Matias, J ;
Mohrenweiser, H .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 75, 2003, 75 :43-68
[5]   Sequence and structure-based prediction of eukaryotic protein phosphorylation sites [J].
Blom, N ;
Gammeltoft, S ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) :1351-1362
[6]  
Bondeson J, 2001, INT J CLIN PRACT, V55, P211
[7]   Cytokines in autoimmunity [J].
Brennan, FM ;
Feldmann, M .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (06) :872-877
[8]  
BRIDGES D, UNPUB 14 3 3 PROTEIN
[9]  
Bridges SL, 2003, CLIN EXP RHEUMATOL, V21, pS138
[10]   Roles of tumor necrosis factor-α receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome [J].
Carballo, E ;
Blackshear, PJ .
BLOOD, 2001, 98 (08) :2389-2395